Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma
- PMID: 31822948
- DOI: 10.1007/s00277-019-03846-0
Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma
References
-
- Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B et al (2009) Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol 2:36 - DOI
-
- Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY (2018) Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol 154:461–466 - DOI
-
- Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol 19:67–77 - DOI
-
- Hu YQ, Yao XX, Zhang JZ, Li WH (2019) Penile pyoderma gangrenosum: successful treatment with thalidomide. Dermatol Ther 32(4):e12952
-
- Dasanu CA, Alexandrescu DT (2009) A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol 82:231–234 - DOI